skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good afternoon,
Looking to add US healthcare to my portfolio. I would appreciate your thoughts and ranking on the following US healthcare and service providers; MCK, BDX, SYK, UNH, HUM and MDT. I am open to other recommendations.
Thank you,
Patrick
Read Answer Asked by Patrick on December 09, 2019
Q: Kalvista flunked a drug trial and the stock was down 20% premarket. Now the stock is up 4%. Any idea why?
Read Answer Asked by hal on December 09, 2019
Q: Hi Team,
I was contemplating buying either TTD, ROKU, or perhaps both. I understand both of these are a play on online advertising, which is no doubt set to be long term trend as more and more of the world gets online. Which do you prefer of these 2 names? And are they too expensive to buy at these levels? Any concerns with either of them at this point? My other part of this question will also be: I already own FB. Given that most if its revenue comes from social media advertising, and they are doing great at what they are doing, is there any reason to buy the other 2 names mentioned for exposure to the future of online advertising? Other than simply diversification? Thanks
Shane.
Read Answer Asked by Shane on December 09, 2019
Q: I'm interested in researching US financial institutions for new investment ideas. Could you provide me with a shortlist of 4 to 5 US companies (e.g., chartered banks and any other financial institutions) that I might consider. Many thanks.
Read Answer Asked by RANDALL on December 09, 2019
Q: Hello Peter and Team,

Cloudera just had another earnings beat quarter. Do you think that this may be a good buying opportunity, now that the buyout of Hortonworks appears to be integrated and the chart is starting to move in the right direction? Relative to other cloud companies, doesn't it seem inexpensive?

Thanks.

Brad
Read Answer Asked by Bradley on December 09, 2019
Q: Hello-I invested in both of the companies early this year. Williams share price has dropped and now yields an eye popping eight per cent. Is that sustainable? What are your thoughts on wmb. I am tempted to buy more. Also, Citibank gave a shout out to enbridge today and it’s current yields are also high. Your thoughts on enb please?
Read Answer Asked by alex on December 09, 2019
Q: NXPI along with KODIAK Science which is up more than 100% in the last month, what are your opinions of the two stocks?
About the PE ratio - on my Globe Invest it has for instance 98.4 TTM (I do not know what that is), is that number too high for you if you were looking to purchase a stock with that number? What would be a more comfortable number? Thanks for providing info that the average investor would not know. Dennis
Read Answer Asked by Dennis on December 09, 2019
Q: I recently asked you for 4-5 core picks for U.S. stocks and you kindly sent them to me that was appreciated. I am trying to keep my stocks organized by sector, which you have also helped me with and wondered what (based on your Sectors) Costco and Disney would be in?
Thank you so much
Margaret
Read Answer Asked by Margaret on December 06, 2019
Q: Hi 5i team,

Like many here, I follow the 5G theme, but there is a proliferation of participants in many facets of the technology. I own KEYS and am happy there. About a year ago, I put INSG on my watch lists. It has been dormant since then but now seems to be breaking out. I don’t see any real catalysts as such. It missed its last earnings report, but I have read some positive reviews on its 5G prospects for hot spots and SaaS. It is a smaller name and I am unlikely to buy it but I was curious as to your thoughts on it.

Thanks again for the insight.
Dave
Read Answer Asked by Dave on December 05, 2019
Q: Listed on Nasdaq as AUPH. After market close today,it was halted pending news.Later it announced positive phase 3 trail results showing that its Voclosporin is much better than Standard of Care in Lupus Nephritis.It plans to file NDA submission to FDA in 1st half of 2020,There will be a conference call @ 8.30am ET on Dec 5 .AUPH closed @ US$8.39 up 0.41 on 4.9m shares.However in After Hours trading it was @ US $18.39 to US$19.00 on total 10.6m shares.Thinking of selling my 1.5% position,p/p Can$8.33 especially if the Price is around US$18.39 to 19.00.Should I sell all or partial.Please provide your usual great advices & services.Thanks
Read Answer Asked by Peter on December 05, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!